Avloquin Tablet

About Avloquin 250 mg Tablet

Avloquin 250 mg tablets contain chloroquine phosphate, an anti-malarial medicine that acts against malaria parasites in the blood and is also used in some other conditions. It is manufactured by Advanced Chemical Industries PLC.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. 4 of them have a lower unit price than Avloquin. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Avloquin 250 mg Tablet?

Avloquin is a tablet form of chloroquine phosphate, an anti-malarial drug. It works against the blood-stage forms of malaria parasites and is used in the treatment of malaria and in suppressing malaria. It is also used in amoebic hepatitis and amoebic abscess, and in discoid and systemic lupus erythematosus and rheumatoid arthritis. Each tablet carries a strength of 250 mg, and the pack holds 10 x 10 tablets. The doctor decides whether this medicine suits your condition and how it should be taken.

Uses of Avloquin

Avloquin is used for the treatment of malaria and for the prevention and suppression of malaria. It is also used for amoebic hepatitis and amoebic abscess, and for discoid and systemic lupus erythematosus and rheumatoid arthritis. It belongs to the anti-malarial group of medicines. Only a doctor can confirm whether it is appropriate for your condition.

How to use Avloquin

Avloquin is a tablet, taken by mouth. The dose and the length of the course are decided by the doctor, who will base them on your condition and on whether the medicine is being used to treat or to suppress malaria. Follow the doctor's instructions exactly. Do not change the dose or stop the course on your own; ask your doctor or pharmacist if anything is unclear.

Side effects of Avloquin

At usual doses, chloroquine is generally well tolerated. Headache and stomach or bowel upset may occur. With prolonged high doses, side effects can be more serious, including skin eruptions, occasional loss of skin colour or hair loss, difficulty in focusing, and blurred vision. Rarely, low platelets, low white cells and aplastic anaemia have been reported, and prolonged therapy carries a risk of irreversible retinal damage. Tell your doctor about any unusual symptoms.

Safety and precautions

Avoid using this medicine during pregnancy if possible, unless the doctor judges that the benefit outweighs the risk for a threatening infection. Caution is needed in people with porphyria who also have liver dysfunction or cirrhosis, as the drug may worsen symptoms, especially in people who drink alcohol. People taking chloroquine continuously at higher doses, or as regular malaria prophylaxis over long periods, need eye examinations at intervals set by the doctor. Ask your doctor first if you are pregnant, breastfeeding, have liver problems, or take other medicines.

Frequently asked questions

What is Avloquin used for and what kind of medicine is it?

It is an anti-malarial medicine containing chloroquine phosphate. It is used to treat malaria and to prevent and suppress it, and also for amoebic hepatitis and amoebic abscess, discoid and systemic lupus erythematosus, and rheumatoid arthritis. A doctor decides if it is right for you.

How should I store Avloquin?

Store the tablets at room temperature in a dry place, away from light. Keep the pack out of reach of children, and do not use tablets that are past their expiry date or that look changed. Ask your pharmacist if you are unsure about storage.

What do the tablet form and the 250 mg strength mean?

Avloquin comes as tablets that are swallowed, and each tablet contains 250 mg of chloroquine phosphate. The strength shows how much of the medicine is in one tablet. The doctor decides the dose and course; do not set it yourself.

What is the price of Avloquin?

The listed price is ৳ 1.32. Ask your pharmacist about availability, and remember that the doctor decides the dose and the length of the course.

Also available as

80 mg/5 ml (Syrup)

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.